Literature DB >> 30562760

Long Noncoding RNA HOTTIP Promotes Mouse Hepatic Stellate Cell Activation via Downregulating miR-148a.

Zhiqin Li, Jia Wang, Qinglei Zeng, Chunling Hu, Jiajia Zhang, Hongyan Wang, Jingya Yan, Hua Li, Zujiang Yu.   

Abstract

BACKGROUND/AIMS: HOTTIP is a critical modulator in human diseases including liver cancer, but its role and molecular biological mechanisms in liver fibrosis are still unclear.
METHODS: The expression profile of HOTTIP during the progression of liver fibrosis was detected in human liver samples and in CCl4-treated mice using qRT-PCR. The expressing sh-HOTTIP adenoviral vector was used to reduce HOTTIP levels in vivo. Dual-Luciferase Reporter Assay was performed to validate the interaction between miR-148a and HOTTIP, TGFBR1, or TGFBR2.
RESULTS: HOTTIP expressions in fibrotic liver samples and cirrhotic liver samples were significantly upregulated compared with healthy liver controls, and cirrhotic samples exhibited the highest levels of HOTTIP. Moreover, HOTTIP expressions were substantially induced in the liver tissues and hepatic stellate cells (HSC) of CCl4-treated mice. Ad-shHOTTIP delivery could alleviate CCl4- induced liver fibrosis in mice. Down-regulation of HOTTIP inhibited the viability and activation of HSCs in vitro, and HOTTIP negatively regulated miR-148a expression in HSCs. miR-148a had a negative effect on HSC activation by targeting TGFBR1 and TGFBR2.
CONCLUSION: HOTTIP is involved in the progression of liver fibrosis by promoting HSC activation. The high level of HOTTIP downregulates miR-148a, thus to increase the level of TGFBR1 and TGFBR2 and contribute to liver fibrosis.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  HOTTIP; HSC activation; Liver fibrosis; miR-148a

Mesh:

Substances:

Year:  2018        PMID: 30562760     DOI: 10.1159/000496012

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  13 in total

1.  Circ_MTM1 knockdown inhibits the progression of HBV-related liver fibrosis via regulating IL7R expression through targeting miR-122-5p.

Authors:  Bin Li; Yonggang Li; Shuhua Li; Hongwei Li; Ling Liu; Haiying Yu
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

Review 2.  Autophagy and apoptosis cascade: which is more prominent in neuronal death?

Authors:  Rohan Gupta; Rashmi K Ambasta
Journal:  Cell Mol Life Sci       Date:  2021-11-06       Impact factor: 9.261

3.  Interplay Between GH-regulated, Sex-biased Liver Transcriptome and Hepatic Zonation Revealed by Single-Nucleus RNA Sequencing.

Authors:  Christine N Goldfarb; Kritika Karri; Maxim Pyatkov; David J Waxman
Journal:  Endocrinology       Date:  2022-07-01       Impact factor: 5.051

4.  LncRNA Neat1 expedites the progression of liver fibrosis in mice through targeting miR-148a-3p and miR-22-3p to upregulate Cyth3.

Authors:  Wei Huang; Feizhou Huang; Rui Zhang; Hongwu Luo
Journal:  Cell Cycle       Date:  2021-02-08       Impact factor: 4.534

5.  miR‑148a‑3p regulates alcoholic liver fibrosis through targeting ERBB3.

Authors:  Jie Xiong; Jianbo Ni; Congying Chen; Kezhou Wang
Journal:  Int J Mol Med       Date:  2020-06-23       Impact factor: 4.101

6.  Role of long non‑coding RNAs and related epigenetic mechanisms in liver fibrosis (Review).

Authors:  Niladri Ganguly; Subrata Chakrabarti
Journal:  Int J Mol Med       Date:  2021-01-26       Impact factor: 4.101

7.  MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway.

Authors:  Yunhong Xia; Lu Zhen; Hongxia Li; Shuomin Wang; Sun Chen; Chongchong Wang; Xiaoyu Yang
Journal:  Cell Death Dis       Date:  2021-03-26       Impact factor: 8.469

8.  Global analysis of expression, maturation and subcellular localization of mouse liver transcriptome identifies novel sex-biased and TCPOBOP-responsive long non-coding RNAs.

Authors:  Christine N Goldfarb; David J Waxman
Journal:  BMC Genomics       Date:  2021-03-24       Impact factor: 3.969

Review 9.  Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets.

Authors:  B Alipoor; S Nikouei; F Rezaeinejad; S-N Malakooti-Dehkordi; Z Sabati; H Ghasemi
Journal:  J Endocrinol Invest       Date:  2021-04-01       Impact factor: 4.256

Review 10.  The Roles and Mechanisms of lncRNAs in Liver Fibrosis.

Authors:  Zhi He; Deying Yang; Xiaolan Fan; Mingwang Zhang; Yan Li; Xiaobin Gu; Mingyao Yang
Journal:  Int J Mol Sci       Date:  2020-02-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.